Rezolute Analyst Ratings
BenzingaApr 19 12:25 ET
Rezolute Analyst Ratings
BenzingaApr 18 07:59 ET
Optimistic Buy Rating for Rezolute's RZ402 Drug Candidate Amid Promising DME Treatment Prospects
TipRanksApr 18 00:35 ET
Rezolute Analyst Ratings
BenzingaApr 9 11:34 ET
Rezolute Analyst Ratings
BenzingaMar 7 07:29 ET
Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), ITeos Therapeutics (ITOS) and Rezolute (RZLT)
TipRanksMar 7 06:30 ET
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and KalVista Pharmaceuticals (KALV)
TipRanksFeb 14 06:20 ET
Rezolute Analyst Ratings
BenzingaFeb 14 06:19 ET
Buy Rating Affirmed for Rezolute Amidst Promising Clinical Developments and Stable Financials
TipRanksFeb 14 00:15 ET
Buy Rating Affirmed for Rezolute's RZ358 Based on Untapped Market Potential and Therapeutic Efficacy
TipRanksFeb 8 06:19 ET
Rezolute's Promising Drug Pipeline and Market Position Validate Buy Rating: An Analysis of RZ358 and RZ402 Potential
TipRanksNov 17, 2023 06:22 ET
JMP Securities Maintains Market Outperform on Rezolute, Lowers Price Target to $7
BenzingaNov 14, 2023 11:31 ET
Rezolute Analyst Ratings
BenzingaNov 14, 2023 11:30 ET
Analysts Are Bullish on Top Healthcare Stocks: Benitec Biopharma (BNTC), Rezolute (RZLT)
TipRanksNov 14, 2023 00:30 ET
Cantor Fitzgerald Reiterates Overweight on Rezolute, Maintains $5 Price Target
BenzingaSep 19, 2023 09:11 ET
Rezolute Analyst Ratings
BenzingaSep 19, 2023 09:10 ET
HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target
BenzingaSep 18, 2023 06:47 ET
Rezolute Analyst Ratings
BenzingaSep 18, 2023 06:46 ET
Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT), TG Therapeutics (TGTX) and Harpoon Therapeutics (HARP)
TipRanksSep 18, 2023 06:20 ET
JMP Securities Reiterates Market Outperform on Rezolute, Maintains $8 Price Target
BenzingaSep 15, 2023 08:30 ET
No Data
No Data